NSEAppointment30 Jun 2026 · 30 Jun 2026, 11:25 pm
Appointment
Zydus Wellness Limited · ZYDUSWELL
✦ AI SummaryMgmt Change
Zydus Wellness Limited has informed the Exchange regarding the appointment of Dr. Shyam Ramakrishnan as Chief Scientific Officer, effective July 1, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Zydus Wellness Limited has informed the Exchange regarding Appointment of Dr. Shyam Ramakrishnan as Other of the company w.e.f. July 01, 2026.
Attachments (1)
📄pdf
Download →
ZYDUSWELL_30062026232259_SEintimationSMP.pdf
View document text
June 30, 2026
Listing Department Code: 531 335
BSE LIMITED
P. J. Towers, Dalal Street,
Mumbai–400 001
Listing Department Code: ZYDUSWELL
NATIONAL STOCK EXCHANGE OF INDIA LIMITED
Exchange Plaza, C/1, Block G,
Bandra Kurla Complex,
Bandra (E),
Mumbai–400 051
Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“the Listing Regulations”) read with the SEBI Master
Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“the
SEBI Master Circular”)
Dear Sir / Madam,
This is to inform that based on the recommendation of Nomination and Remuneration
Committee, the Board of Directors of Zydus Wellness Limited have approved appointment of
Dr. Shyam Ramakrishnan as Chief Scientific Officer forming part of Senior Management of the
Company with effect from July 1, 2026.
The requisite details as stipulated under Regulation 30 of the Listing Regulations read with
clause 7 of Para A of Part A of Schedule III read with SEBI Master Circular are provided in attached
Annexure-“1”.
We request you to kindly take this on record.
Yours faithfully,
For, ZYDUS WELLNESS LIMITED
NANDISH P. JOSHI
COMPANY SECRETARY & COMPLIANCE OFFICER
Encl. As above
Annexure-“1”
Sr. Particulars Details
1. Reason for change viz. Dr. Shyam Ramakrishnan is appointed as Chief
appointment, re-appointment, Scientific Officer, forming part of Senior
resignation, removal, death or Management of the Company.
otherwise.
2. Date of appointment / D a t e a n d t e r m o f appointment: July 1, 2026.
re-appointment / cessation (as Term of appointment: Full-time contract.
applicable) and term of
appointment / re-appointment.
3. Brief profile (in case of Dr. Shyam Ramakrishnan holds a PhD in
appointment). Biological Chemistry & Genetics from the
University of Texas and has completed
postdoctoral fellowships at Harvard Medical
School and Hoffmann-La Roche.
He brings with him over 25 years of rich
experience across nutrition, dietary
supplements, beauty, personal care, and
functional foods. He brings a wealth of
experience and expertise in the field of
translational science, clinical research,
bioinformatics, and innovation platform
development, along with leading large cross-
functional teams across the US, India, Southeast
Asia, and other international markets having
served in Key Leadership roles with
organizations like Hill’s Pet Nutrition, The
Himalaya Drug Company, ITC Ltd., and Amway
(United States, Southeast Asia & Brazil).
4. Disclosure of relationships Not applicable.
between directors (in case of
appointment of a director).